Weijie Wang

Weijie Wang is an accomplished professional in the field of Chemistry with a Ph.D. from the University of Alberta. Currently serving as Vice President of CMC at TCG Labs Soleil since August 2024, Weijie has previously held significant roles including Head of Analytical Sciences & CMC at Oncternal Therapeutics, Director at Gilead Sciences, and Director of Analytical Development at both Forty Seven Inc. and Incyte. Additional experience includes a tenure as Principal Scientist at Teva Pharmaceuticals and Sr. Scientist I at Human Genome Sciences. Early career experience includes a position as a Scientist at Calibrant Biosystems.